AI technology predicts pancreatic cancer recurrence from pathology slides
Audio narration · Coming soon
This research demonstrates that AI can analyze pathology slides to predict the recurrence of pancreatic cancer. These insights have the potential to improve personalized patient surveillance, tailor adjuvant therapy, and inform clinical trial design.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews